SCULLY WILLIAM P purchased $1.2M of PRTA
SCULLY WILLIAM P purchased 150,000 shares of PROTHENA CORP PUBLIC LTD CO (PRTA) at an average of $8.15 ($8.07–$8.19, $1.22M total) across 2 trades over 2026-10-22 to 2026-10-23.
How this was made
The 30-second read
Why it matters
The transaction adds a modest amount of buying pressure and signals insider confidence, but the overall market impact is limited.
Market read
Primary relevance is to traders monitoring insider activity; limited broader market effect.
What to watch
Potential upcoming catalyst (e.g., trial data) not disclosed could be the real driver of the purchase.
Background
SEC Form 4 filing discloses an insider purchase of PRTA shares.
Ticker impact
Form 4 shows insider Scully William P bought 150,000 shares for $1.22M, increasing his stake to 1,187,000 shares (10% owner).
likely modest upward pressure as market prices in insider confidence
The purchase is sizable for a micro‑cap and comes from a 10% owner, but the total amount is modest relative to market cap.
Market effects
Minimal; insider activity may slightly influence peer perception in the biotech sector.
None; the filing is company‑specific.
Low; no broader market effect.
Counterpoint
The purchase could be a defensive move to support the stock price rather than a bullish signal.
Key entities
- companyProthena Corp Public Ltd Co
Biotech company listed on NASDAQ under ticker PRTA.
- insiderScully William P
10% owner of Prothena who made the purchase.
